WuXi AppTec Completes Sale of Two Units to Hillhouse Investment

MT Newswires Live
2025/12/16

WuXi AppTec (HKG:2359) has completed the sale of its WuXi Clinical Development Services (Shanghai) and WuXi MedKey Med-Tech Development (Shanghai) units to asset manager Hillhouse Investment Management, according to a Hong Kong bourse filing Monday.

Shares of the drug research company fell over 1% in midday trade Tuesday.

The firm said it received the first installment payment of the consideration in the amount of 1.54 billion yuan.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10